These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6782233)

  • 1. Sulfonamide inhibition of bone resorption: lack of a hypophosphatemia.
    Waite LC; Pierce WM; Lineberry MD
    J Pharmacol Exp Ther; 1980 Jun; 213(3):441-4. PubMed ID: 6782233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidosis inhibits the hypocalcemic effect of acetazolamide.
    Lineberry MD; Waite LC
    J Pharmacol Exp Ther; 1979 Dec; 211(3):452-5. PubMed ID: 41935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of action of thyrocalcitonin: inhibition with acetazolamide.
    Stahl PD; Kenny AD
    Endocrinology; 1969 Jul; 85(1):161-4. PubMed ID: 4977681
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetazolamide inhibition of bone resorption: lack of effect on phosphate release from bone in vitro.
    Pierce WM; Waite LC
    Horm Metab Res; 1981 Oct; 13(10):591-2. PubMed ID: 7298015
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypocalcemic effect of phentolamine.
    Waite LC; Lineberry MD
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):403-16. PubMed ID: 653098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bone resorption by acetazolamide in the rat.
    Waite LC; Volkert WA; Kenny AD
    Endocrinology; 1970 Dec; 87(6):1129-39. PubMed ID: 4320594
    [No Abstract]   [Full Text] [Related]  

  • 7. The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition.
    Torring MS; Holmgaard K; Hessellund A; Aalkjaer C; Bek T
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):345-51. PubMed ID: 18757514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo inhibition of bone resorption by thyrocalcitonin.
    Wallach S; Chausmer A; Mittleman R; Dimich A
    Endocrinology; 1967 Jan; 80(1):61-4. PubMed ID: 6029404
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucagon as a hypocalcemic and hypophosphatemic agent in the rat.
    Aliapoulios MA; Morain WD; Kacoyanis GP
    Gastroenterology; 1973 Dec; 65(6):912-8. PubMed ID: 4753349
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the effects of thyrocalcitonin and glucagon on plasma calcium and phosphate.
    Tanzer FS; Kennedy JW; Talmage RV
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):500-5. PubMed ID: 5414235
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcitonin on the rates of bone formation and resorption in the rat.
    Baylink D; Morey E; Rich C
    Endocrinology; 1969 Feb; 84(2):261-9. PubMed ID: 4974375
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro effects of a pulsed electromagnetic field on net calcium flux in rat calvarial bone.
    Spadaro JA; Bergstrom WH
    Calcif Tissue Int; 2002 Jun; 70(6):496-502. PubMed ID: 11976773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour growth inhibition by calcitonin: role of the age of the animal and the hypocalcemic response.
    Anghileri LJ; Delbrück H; Cressent M; Pidoux E
    Arch Geschwulstforsch; 1980; 50(7):635-9. PubMed ID: 7235863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of calcitonin on skeletal mass in osteoporotic castrate female rats.
    Saville PD
    Clin Orthop Relat Res; 1970; 69():285-8. PubMed ID: 5445355
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcitonin inhibition of bone cell metabolism in vivo: an experimental study in dogs.
    Singh M; Lin C; Post M
    Endocrinology; 1975 Jun; 96(6):1468-74. PubMed ID: 236172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity to calcitonin after ovariectomy.
    Gozariu L; Florescu O; Toader S
    Endocrinologie; 1979; 17(2):133-5. PubMed ID: 462110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of calcitonin and indomethacin on bone resorption mediated by interleukin-1].
    Zhang WZ; Yu SF; Zheng LF
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):530-2, 581-2. PubMed ID: 7842348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens and enhancement of hypocalcemic response to thyrocalcitonin in rats.
    Ogata E; Shimazawa E; Suzuki H; Yoshitoshi Y; Asano H; Ando H
    Endocrinology; 1970 Aug; 87(2):421-6. PubMed ID: 5425004
    [No Abstract]   [Full Text] [Related]  

  • 20. The diurnal rhythm of bone resorption in the rat. Effect of feeding habits and pharmacological inhibitors.
    Mühlbauer RC; Fleisch H
    J Clin Invest; 1995 Apr; 95(4):1933-40. PubMed ID: 7706501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.